CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications

Rita Azevedo1,2, Cristiana Gaiteiro1,2,3, Andreia Peixoto1,2,4

  • 11Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.

Clinical Proteomics
|July 10, 2018
PubMed

Insights

CD44, a key cell receptor, presents diverse forms in cancer, impacting treatment. Systematizing its nomenclature and exploring its glycosylation and splicing are crucial for discovering new cancer biomarkers and neoantigens.

Area of Science:

  • Molecular Biology
  • Glycobiology
  • Cancer Research

Background:

  • CD44 is a heavily glycosylated membrane receptor involved in cell adhesion, signaling, and cytoskeleton organization.
  • It is a significant target in cancer research, linked to cancer stem cells, chemoresistance, and metastasis.
  • CD44 exists as a family of splicing variants with diverse glycosylation, leading to complex roles and nomenclature challenges.

Purpose of the Study:

  • To comprehensively address CD44's structural diversity and systematize its nomenclature for biomarker discovery.
  • To explore CD44 as a potential source of cancer neoantigens arising from altered splicing and glycosylation.
  • To establish milestones for advancing CD44-related biomarker discovery in clinical settings.

Main Methods:

  • Systematic review and analysis of CD44 structure, function, and nomenclature.
  • Integration of glycomics with proteogenomics approaches.
  • Utilizing customized protein sequence databases generated via genomics and transcriptomics.

Main Results:

  • Identified structural diversity and ambiguous nomenclature as significant hurdles in CD44 clinical development.
  • Proposed CD44 (glyco)isoforms as potential sources of cancer neoantigens due to altered splicing and glycosylation.
  • Highlighted the availability of advanced analytical and bioinformatics tools for CD44 research.

Conclusions:

  • Systematizing CD44 nomenclature is essential for unlocking its potential as a biomarker.
  • Targeting specific CD44 (glyco)isoforms requires integrated glycomics and proteogenomics strategies.
  • CD44 research holds promise for identifying novel cancer neoantigens and improving therapeutic strategies.

Related Concept Videos

Applications of Molecular Taxonomy01:20

Applications of Molecular Taxonomy

Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
572
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.5K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
760
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
5.1K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
1.4K